Tristel Plc (LON:TSTL) had its price target hoisted by stock analysts at FinnCap from GBX 165 ($2.14) to GBX 195 ($2.53) in a report issued on Monday, MarketBeat.com reports. The brokerage presently has a “corporate” rating on the stock. FinnCap’s target price would suggest a potential downside of 2.11% from the stock’s current price.

Tristel Plc (LON:TSTL) traded up 6.82% on Monday, reaching GBX 203.50. 38,488 shares of the company’s stock were exchanged. The firm has a 50 day moving average of GBX 199.94 and a 200 day moving average of GBX 181.88. Tristel Plc has a 12 month low of GBX 87.11 and a 12 month high of GBX 214.96. The stock’s market capitalization is GBX 85.58 million.

ILLEGAL ACTIVITY WARNING: “Tristel Plc (LON:TSTL) PT Raised to GBX 195 at FinnCap” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.americanbankingnews.com/2017/07/03/tristel-plc-lontstl-pt-raised-to-gbx-195-at-finncap.html.

About Tristel Plc

Tristel Plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company’s technology is a chlorine dioxide formulation. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used primarily for infection control in hospitals.

Receive News & Ratings for Tristel Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel Plc and related companies with MarketBeat.com's FREE daily email newsletter.